Report Detail
Global Latanoprost Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4656584 |
- 05 December, 2025 |
- Global |
- 98 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Latanoprost market size was valued at US$ 1476 million in 2024 and is forecast to a readjusted size of USD 1710 million by 2031 with a CAGR of 2.1% during review period.
Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.
In the report, one unit refers to one bottle.
Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.
This report is a detailed and comprehensive analysis for global Latanoprost market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Latanoprost market size and forecasts, in consumption value ($ Million), sales quantity (M Unit), and average selling prices (USD/Unit), 2020-2031
Global Latanoprost market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Unit), and average selling prices (USD/Unit), 2020-2031
Global Latanoprost market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Unit), and average selling prices (USD/Unit), 2020-2031
Global Latanoprost market shares of main players, shipments in revenue ($ Million), sales quantity (M Unit), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Latanoprost
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Latanoprost market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Mylan, Novartis, Apotex, Teva, Taj Pharma, CR Zizhu, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Latanoprost market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Brand Drug
Generic Drug
Market segment by Application
Open-angle Glaucoma
Close-angle Glaucoma
Major players covered
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Latanoprost product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Latanoprost, with price, sales quantity, revenue, and global market share of Latanoprost from 2020 to 2025.
Chapter 3, the Latanoprost competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Latanoprost breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Latanoprost market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Latanoprost.
Chapter 14 and 15, to describe Latanoprost sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Latanoprost Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Brand Drug
- 1.3.3 Generic Drug
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Latanoprost Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Open-angle Glaucoma
- 1.4.3 Close-angle Glaucoma
- 1.5 Global Latanoprost Market Size & Forecast
- 1.5.1 Global Latanoprost Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Latanoprost Sales Quantity (2020-2031)
- 1.5.3 Global Latanoprost Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Pfizer
- 2.1.1 Pfizer Details
- 2.1.2 Pfizer Major Business
- 2.1.3 Pfizer Latanoprost Product and Services
- 2.1.4 Pfizer Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Pfizer Recent Developments/Updates
- 2.2 Mylan
- 2.2.1 Mylan Details
- 2.2.2 Mylan Major Business
- 2.2.3 Mylan Latanoprost Product and Services
- 2.2.4 Mylan Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Mylan Recent Developments/Updates
- 2.3 Novartis
- 2.3.1 Novartis Details
- 2.3.2 Novartis Major Business
- 2.3.3 Novartis Latanoprost Product and Services
- 2.3.4 Novartis Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Novartis Recent Developments/Updates
- 2.4 Apotex
- 2.4.1 Apotex Details
- 2.4.2 Apotex Major Business
- 2.4.3 Apotex Latanoprost Product and Services
- 2.4.4 Apotex Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Apotex Recent Developments/Updates
- 2.5 Teva
- 2.5.1 Teva Details
- 2.5.2 Teva Major Business
- 2.5.3 Teva Latanoprost Product and Services
- 2.5.4 Teva Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Teva Recent Developments/Updates
- 2.6 Taj Pharma
- 2.6.1 Taj Pharma Details
- 2.6.2 Taj Pharma Major Business
- 2.6.3 Taj Pharma Latanoprost Product and Services
- 2.6.4 Taj Pharma Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Taj Pharma Recent Developments/Updates
- 2.7 CR Zizhu
- 2.7.1 CR Zizhu Details
- 2.7.2 CR Zizhu Major Business
- 2.7.3 CR Zizhu Latanoprost Product and Services
- 2.7.4 CR Zizhu Latanoprost Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 CR Zizhu Recent Developments/Updates
3 Competitive Environment: Latanoprost by Manufacturer
- 3.1 Global Latanoprost Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Latanoprost Revenue by Manufacturer (2020-2025)
- 3.3 Global Latanoprost Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Latanoprost by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Latanoprost Manufacturer Market Share in 2024
- 3.4.3 Top 6 Latanoprost Manufacturer Market Share in 2024
- 3.5 Latanoprost Market: Overall Company Footprint Analysis
- 3.5.1 Latanoprost Market: Region Footprint
- 3.5.2 Latanoprost Market: Company Product Type Footprint
- 3.5.3 Latanoprost Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Latanoprost Market Size by Region
- 4.1.1 Global Latanoprost Sales Quantity by Region (2020-2031)
- 4.1.2 Global Latanoprost Consumption Value by Region (2020-2031)
- 4.1.3 Global Latanoprost Average Price by Region (2020-2031)
- 4.2 North America Latanoprost Consumption Value (2020-2031)
- 4.3 Europe Latanoprost Consumption Value (2020-2031)
- 4.4 Asia-Pacific Latanoprost Consumption Value (2020-2031)
- 4.5 South America Latanoprost Consumption Value (2020-2031)
- 4.6 Middle East & Africa Latanoprost Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Latanoprost Sales Quantity by Type (2020-2031)
- 5.2 Global Latanoprost Consumption Value by Type (2020-2031)
- 5.3 Global Latanoprost Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Latanoprost Sales Quantity by Application (2020-2031)
- 6.2 Global Latanoprost Consumption Value by Application (2020-2031)
- 6.3 Global Latanoprost Average Price by Application (2020-2031)
7 North America
- 7.1 North America Latanoprost Sales Quantity by Type (2020-2031)
- 7.2 North America Latanoprost Sales Quantity by Application (2020-2031)
- 7.3 North America Latanoprost Market Size by Country
- 7.3.1 North America Latanoprost Sales Quantity by Country (2020-2031)
- 7.3.2 North America Latanoprost Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Latanoprost Sales Quantity by Type (2020-2031)
- 8.2 Europe Latanoprost Sales Quantity by Application (2020-2031)
- 8.3 Europe Latanoprost Market Size by Country
- 8.3.1 Europe Latanoprost Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Latanoprost Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Latanoprost Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Latanoprost Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Latanoprost Market Size by Region
- 9.3.1 Asia-Pacific Latanoprost Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Latanoprost Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Latanoprost Sales Quantity by Type (2020-2031)
- 10.2 South America Latanoprost Sales Quantity by Application (2020-2031)
- 10.3 South America Latanoprost Market Size by Country
- 10.3.1 South America Latanoprost Sales Quantity by Country (2020-2031)
- 10.3.2 South America Latanoprost Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Latanoprost Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Latanoprost Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Latanoprost Market Size by Country
- 11.3.1 Middle East & Africa Latanoprost Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Latanoprost Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Latanoprost Market Drivers
- 12.2 Latanoprost Market Restraints
- 12.3 Latanoprost Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Latanoprost and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Latanoprost
- 13.3 Latanoprost Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Latanoprost Typical Distributors
- 14.3 Latanoprost Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Latanoprost. Industry analysis & Market Report on Latanoprost is a syndicated market report, published as Global Latanoprost Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Latanoprost market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
